Sara Frank will join two panel discussions at the Pharmaceutical and Medical Device Ethics and Compliance Congress on October 22-23, 2025. Sara will moderate the panel, “Integrating Compliance into Vendor/Consultant Engagements” on Wednesday, October 22nd at 11:00 a.m., which will discuss practical approaches for incorporating compliance controls into engagements with vendors and consultants, including a review of the various inflection points where Compliance and Legal oversight may be useful in risk assessment, engagement, implementation, and monitoring. On October 23rd at 9:00 a.m., Sara will join the panel, “Compliance Considerations for Mergers and Acquisitions” as a speaker, exploring the critical compliance considerations that organizations must address during mergers and acquisitions in the sector. Please visit the online agenda for more information about the Compliance Congress or to register.